FDA conducted inspections of 2 companies in City of St. Louis in March

Jim Traficant, Chief of Staff of FDA
Jim Traficant, Chief of Staff of FDA
0Comments

There were two companies in the City of St. Louis, Missouri, that received two FDA inspections in March, according to the U.S. Food and Drug Administration (FDA).

This is a 60% decrease from the number of companies inspected in the previous month, when five companies received five inspections.

The companies inspected operate in the Food and Cosmetics sector.

Both companies were in line with FDA regulations, and don’t need to adjust their managing operations or regulatory/administrative actions.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.

Companies Located in City of St. Louis and Their Inspection Results
Company NameArea of BusinessInspection DateResult
MilliporeSigmaFood and Cosmetics03/18/2026No Action Indicated (NAI)
Ted Drewes, Inc.Food and Cosmetics03/12/2026No Action Indicated (NAI)
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.



Related

Tom Oliverson, M.D., Majority leader of Texas House of Representatives

Rep. Oliverson calls for transparency in Texas’ 340B program, while oversight concerns continue to grow in Missouri

Rep. Tom Oliverson called for greater transparency in the 340B Drug Pricing Program, raising concerns about its effects on the pharmaceutical supply chain and benefits received by certain pharmacies.

Kalvin Pugh, 340B policy director at Community Access National Network

CANN Policy Director Pugh on 340B reforms: ‘Missouri lawmakers have an opportunity to lead by implementing common-sense reforms’

Kalvin Pugh of Community Access National Network called for greater transparency in Missouri’s use of the federal 340B Drug Pricing Program on May 2.

Kalvin Pugh, 340B policy director at Community Access National Network

CANN Policy Director Pugh on 340B reforms: ‘Missouri lawmakers have an opportunity to lead by implementing common-sense reforms’

Kalvin Pugh of Community Access National Network called for greater transparency in Missouri’s use of the federal 340B Drug Pricing Program on May 2.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from St. Louis Reporter.